Glaxosmithkline recently advertised 'Avandia' the most widely studied oral anti-diabetic medicine for tretment of type 2 diabetes. The advertisement includes scientific evidence available to address the question of side effects. The extensive data includes 166 clinical trials in over 52,000 patients. These includes:
Heart attack -the number of heart attacks across all sources of data is small
CV death - the long term trials provide no evidence of increased cv death
Stroke - fewer strokes are observed with 'Avandia' than with other anti-diabetic medicines
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment